M1A.251 Drug-induced chronic gout, right hip

Name of the Condition

• Drug-Induced Chronic Gout, Right Hip

Summary

Drug-induced chronic gout, right hip is a form of arthritis affecting the right hip joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and may involve the formation of tophi (urate crystal deposits) in advanced stages.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the right hip joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense right hip pain, often with swelling and redness
• Persistent warmth and tenderness in the affected hip
• Formation of tophi (hard, painless lumps) around the hip joint
• Stiffness and limited range of motion in the right hip
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis confirms urate crystal presence. Imaging (e.g., X-ray, ultrasound) assesses joint damage and tophi. The right hip is specifically evaluated to confirm site involvement.

Treatment Options

Treatment focuses on reducing uric acid levels and managing symptoms. Medications may include urate-lowering agents (e.g., allopurinol) and anti-inflammatories for flare-ups. Lifestyle modifications, such as dietary changes and hydration, support management. In severe cases, tophi removal or joint repair may be considered.

Prognosis and Follow-Up

With proper treatment, symptoms can be controlled, and joint damage may be minimized. Regular follow-up monitors uric acid levels and treatment efficacy. Untreated cases may lead to progressive joint damage and disability. Adherence to medication and lifestyle changes improves outcomes.

Complications

• Chronic joint damage and deformity in the right hip
• Persistent pain and reduced mobility
• Development of tophi, which may ulcerate or become infected
• Increased risk of kidney stones or renal impairment

Lifestyle & Prevention

• Avoid medications known to raise uric acid (if possible, under medical guidance)
• Maintain a balanced diet low in purines (e.g., limit red meat, seafood)
• Stay hydrated to support uric acid excretion
• Limit alcohol, especially beer, which can trigger flare-ups
• Engage in regular, low-impact exercise to preserve joint function

When to Seek Professional Help

Seek care if experiencing severe or worsening right hip pain, swelling, or stiffness. Prompt evaluation is needed for sudden flare-ups or signs of infection (e.g., fever, redness). Consult a healthcare provider for persistent symptoms or if medications cause side effects.

Tips for Medical Coders

Document the specific site (right hip) and confirm drug-induced etiology. Ensure clinical notes support the diagnosis, including medication history and site-specific findings. Code M1A.251 is used when the right hip is the affected site; verify no other site is documented to avoid miscoding.